Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078964 | SCV000110829 | benign | not specified | 2013-05-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078964 | SCV000304467 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000477122 | SCV000561552 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311564 | SCV000845922 | benign | Inborn genetic diseases | 2015-11-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001650900 | SCV001865156 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504990 | SCV002798081 | benign | Acquired hemoglobin H disease; Alpha thalassemia-X-linked intellectual disability syndrome; Intellectual disability-hypotonic facies syndrome, X-linked, 1 | 2022-02-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001650900 | SCV005274728 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000078964 | SCV000150399 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV000477122 | SCV001462650 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |